Edge Pharmacy Services offers compounded Mitomycin bladder instillation syringe kits that include a 40mg/40mL pre-filled unit-dose syringe of Mitomycin, a closed system transfer device (CSTD), and catheter tip. The CSTD is attached by Edge in an ISO 5 environment according to CGMP. This solution solves the USP 800 hazardous compounding challenge many hospitals and clinics now face when trying to administer Mitomycin. Since the product comes ready-to-administer, you do not need to compound a hazardous drug in your facility. Edge specializes in offering hazardous compounding services for organizations, making the transition to USP 800 compliance easier.
Mitomycin Bladder Instillation Kit
Available Dosage = 40 mg
Syringe Volume = 40 mL
Closed system transfer device (CSTD) and catheter tip included with kit
* Custom dosages available upon request.
1) Mian, Badar. "Immediate Post-TURBT Mitomycin Instillation Reduces Recurrence Risk." Urology Times, Vol. 45 Issue 12, Nov. 2017: p. 9.
"Mitomycin C (MMC) instillation within 24 hours after transurethral resection (TURBT) of non-muscle invasive bladder cancer (NMIBC) significantly reduces the risk of recurrence and delays the time to recurrence."
"The recurrence risk in the entire cohort was significantly lower at 27% in the immediate instillation group compared to 36% in the delayed instillation group (p<.001)."
Create an account to orderLog-In if you have an account